Financial Consulate’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Financial Consulate's REGN Position: Q1 2026 in Review
Financial Consulate increased its Regeneron Pharmaceuticals (REGN) stake by 67% in Q1 2026, buying an estimated $6.13K and bringing the position to 20 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #544.
Financial Consulate first reported a position in REGN in Q3 2025 and has held it in 3 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Financial Consulate held 20 shares of Regeneron Pharmaceuticals worth $15.5K as of Q1 2026.
- Financial Consulate bought 8 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $6.13K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #544 holding.
- Financial Consulate first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.